Trials / Unknown
UnknownNCT05099978
Asian Multicenter Prospective Study of ctDNA Sequencing
Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 506 (estimated)
- Sponsor
- National Cancer Center, Japan · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a genetic analysis of aberrations in circulating tumor DNA (ctDNA) in patients in Asian countries. This study protocol is divided into parts describing several subanalyses that differ in terms of cancer types, analytical methods, participating countries, and participating institutions.
Detailed description
NGS analysis will be performed on cfDNA extracted from peripheral blood samples of target patients to determine the types and incidences of genetic abnormalities. Patient information and gene abnormality data will be integrated, and the types and incidences of gene abnormalities by cancer type will be analyzed.
Conditions
- Cervical Cancer
- Ovarian Clear Cell Carcinoma
- Nasopharyngeal Carcinoma
- Ovarian Cancer
- Endometrial Cancer
- Triple Negative Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | NGS analysis of ctDNA | Diagnostic Test: plasma circulating tumor DNA |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2021-10-29
- Last updated
- 2024-09-04
Locations
19 sites across 8 countries: Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
Source: ClinicalTrials.gov record NCT05099978. Inclusion in this directory is not an endorsement.